Given these differences, selecting the right GLP-1RA should be based on individual patient needs, including glycemic targets, weight loss goals, tolerability, and preference for dosing frequency
These effects usually improve over time as your body adjusts to the medication or the new dose
The incidence risk ratio (IRR) was 0.82 for continuous GLP-1RA use, 0.88 for interrupted use, and 0.96 for discontinued use, relative to sulfonylurea use
Springer: R
Popular GLP-1 medications include semaglutide (Ozempic for diabetes, Wegovy for weight loss) and dulaglutide (Trulicity)
Conclusion Maximizing the benefits of GLP-1 therapies require a multidisciplinary approach that integrates evidence-based nutrition, physical activity, and proactive management of gastrointestinal side effects